Genus Plc (GNS) - Financial and Strategic SWOT Analysis Review

Date: November 15, 2016
Pages: 42
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: G3AB81603FEEN
Leaflet:

Download PDF Leaflet

Genus Plc (GNS) - Financial and Strategic SWOT Analysis Review
Genus Plc (GNS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Genus plc (Genus) is a global animal genetic company. The company is involved in the application of quantitative genetics and biotechnology to animal breeding primarily in two sectors, namely, bovine and porcine. The primary activities of the company include supply of dairy and beef cattle semen under ABS trademark; supply of pigs and their semen under PIC trade mark; and other value added and technical support services. The key customers of the company include farmers, breeders, processors, distributors, retailers, and consumers. The company has its operations in North America, Latin America, Europe and Far East. It has its research and development (R&D) laboratories in Madison, Wisconsin. Genus is headquartered in Basingstoke, the UK.

Genus Plc Key Recent Developments

Sep 08, 2016: Genus: Preliminary Results for the year ended 30 June 2016 Significant Strategic Progress and Continued Profit Growth
Sep 07, 2016: Genus Announces Non-Executive Director Retirement
Aug 15, 2016: Genus: Final Jury Decisions in US Litigation
Aug 12, 2016: Genus: Further Decisions in US Litigation
Mar 04, 2016: Genus announces board of director

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company. - The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably. - Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance. - Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research. - Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Genus Plc - Key Facts
Genus Plc - Key Employees
Genus Plc - Key Employee Biographies
Genus Plc - Major Products and Services
Genus Plc - History
Genus Plc - Company Statement
Genus Plc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Genus Plc - Business Description
Genus Plc - Corporate Strategy
Genus Plc - SWOT Analysis
SWOT Analysis - Overview
Genus Plc - Strengths
Genus Plc - Weaknesses
Genus Plc - Opportunities
Genus Plc - Threats
Genus Plc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Genus Plc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Genus Plc, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Genus Plc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Sep 08, 2016: Genus: Preliminary Results for the year ended 30 June 2016 Significant Strategic Progress and Continued Profit Growth
Sep 07, 2016: Genus Announces Non-Executive Director Retirement
Aug 15, 2016: Genus: Final Jury Decisions in US Litigation
Aug 12, 2016: Genus: Further Decisions in US Litigation
Mar 04, 2016: Genus announces board of director

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer 42

LIST OF TABLES

Genus Plc, Key Facts
Genus Plc, Key Employees
Genus Plc, Key Employee Biographies
Genus Plc, Major Products and Services
Genus Plc, History
Genus Plc, Subsidiaries
Genus Plc, Key Competitors
Genus Plc, Ratios based on current share price
Genus Plc, Annual Ratios
Genus Plc, Interim Ratios
Genus Plc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Genus Plc, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Genus Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios 41

LIST OF FIGURES

Genus Plc, Performance Chart (2012 - 2016)
Genus Plc, Ratio Charts
Genus Plc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Genus Plc, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016
Skip to top


Ask Your Question

Genus Plc (GNS) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: